Ramón C - Search Results

1

Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks.

Oterino A, Ramón C, Pascual J. Oterino A, et al. Among authors: ramon c. J Headache Pain. 2011 Apr;12(2):235-8. doi: 10.1007/s10194-011-0294-8. Epub 2011 Feb 5. J Headache Pain. 2011. PMID: 21298315 Free PMC article. Clinical Trial.

2

CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.

Cernuda-Morollón E, Martínez-Camblor P, Ramón C, Larrosa D, Serrano-Pertierra E, Pascual J. Cernuda-Morollón E, et al. Among authors: ramon c. Headache. 2014 Jun;54(6):987-95. doi: 10.1111/head.12372. Epub 2014 May 6. Headache. 2014. PMID: 24673487

3

Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.

Cernuda-Morollón E, Martínez-Camblor P, Alvarez R, Larrosa D, Ramón C, Pascual J. Cernuda-Morollón E, et al. Among authors: ramon c. Cephalalgia. 2015 Apr;35(4):310-6. doi: 10.1177/0333102414535111. Epub 2014 May 20. Cephalalgia. 2015. PMID: 24847167

4

Clues in the differential diagnosis of primary vs secondary cough, exercise, and sexual headaches.

Alvarez R, Ramón C, Pascual J. Alvarez R, et al. Among authors: ramon c. Headache. 2014 Oct;54(9):1560-2. doi: 10.1111/head.12449. Epub 2014 Oct 9. Headache. 2014. PMID: 25298032 Review.

5

Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?

Cernuda-Morollón E, Ramón C, Larrosa D, Alvarez R, Riesco N, Pascual J. Cernuda-Morollón E, et al. Among authors: ramon c. Cephalalgia. 2015 Sep;35(10):864-8. doi: 10.1177/0333102414561873. Epub 2014 Nov 27. Cephalalgia. 2015. PMID: 25431141

6

OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine.

Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J. Cernuda-Morollón E, et al. Among authors: ramon c. Pain. 2015 May;156(5):820-824. doi: 10.1097/j.pain.0000000000000119. Pain. 2015. PMID: 25735000

7

What differences exist in the appropriate treatment of congenital versus acquired adult Chiari type I malformation?

Ramón C, Gonzáles-Mandly A, Pascual J. Ramón C, et al. Curr Pain Headache Rep. 2011 Jun;15(3):157-63. doi: 10.1007/s11916-011-0182-6. Curr Pain Headache Rep. 2011. PMID: 21327965 Review.

8

Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.

Cernuda-Morollón E, Larrosa D, Ramón C, Vega J, Martínez-Camblor P, Pascual J. Cernuda-Morollón E, et al. Among authors: ramon c. Neurology. 2013 Oct 1;81(14):1191-6. doi: 10.1212/WNL.0b013e3182a6cb72. Epub 2013 Aug 23. Neurology. 2013. PMID: 23975872

9

No Relationship Between Patent Foramen Ovale and Migraine Frequency.

Larrosa D, Ramón C, Alvarez R, Martínez-Camblor P, Cernuda E, Pascual J. Larrosa D, et al. Among authors: ramon c. Headache. 2016 Oct;56(9):1466-1473. doi: 10.1111/head.12945. Epub 2016 Sep 16. Headache. 2016. PMID: 27634435

10

Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.

Ramón C, Cernuda-Morollón E, Pascual J. Ramón C, et al. Curr Opin Neurol. 2017 Jun;30(3):281-286. doi: 10.1097/WCO.0000000000000440. Curr Opin Neurol. 2017. PMID: 28234796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters